4/12/2010

Cephalon finalized its acquisition of Mepha, a Swiss generic-drug firm, expanding the company's presence in Europe. Cephalon Europe President Alain Aragues said the purchase allows for a more balanced and diverse business in Europe, Africa and the Middle East.

Related Summaries